| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 3.18 | 0.00 (0.00%) | 2.53 - 34.80 | 0.0 |
Market data as of 3:59PM 06/19/13. Quotes are delayed by at least 15 min.
Oxygen Biotherapeutics Reports Successful Completion of FDA Requested Immunocompetency Studies on Oxycyte®
06/18/2013 4:35 PM ET
Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer
05/21/2013 10:30 AM ET
Oxygen Biotherapeutics Receives Favorable NASDAQ Listing Decision
05/16/2013 10:21 AM ET